Julie So-young Kim

CEO - ELECT · TAKEDA PHARMACEUTICAL CO LTD · CIK 0001977732

FILING MIX · LIFETIME100%/0%

BUYS

SELLS

TOTAL VALUE

COMPANIES

ACTIVE SINCE

Apr 2026

HOLDINGS NOW

480,579

AVG SELL PX

—

Trades · vs SPY

Loading price series…

Performance · forward returns vs SPY

No backtest data available for Julie So-young Kim. Backtests are computed for purchase (P) and sale (S) transactions with resolvable price history.

Holdings over time

TAK · 480,579 shares · as of Jul 1, 2026

Trading cadence · quarterly flow

BUY ● SELL ●

2026

FLOW · 5 buys / 0 sellsCOVERAGE · 2 quarters

Form 4 filings · all activity

COMPANY	TYPE	SHARES	PRICE	VALUE	HELD AFTER	TRADE DATE	FILED	DETAILS
TAK TAKEDA PHARMACEUTICAL CO LTD	PURCHASEGRANT Stock grant	50,434	—	—	480,579	Jul 1, 2026	Jul 6, 2026 ↗	View →
TAK TAKEDA PHARMACEUTICAL CO LTD	PURCHASEGRANT Stock grant	7,741	—	—	7,741	Jul 1, 2026	Jul 6, 2026 ↗	View →
TAK TAKEDA PHARMACEUTICAL CO LTD	PURCHASEGRANT Stock grant	7,743	—	—	7,743	Jul 1, 2026	Jul 6, 2026 ↗	View →
TAK TAKEDA PHARMACEUTICAL CO LTD	PURCHASEGRANT Stock grant	22,800	—	—	22,800	Jul 1, 2026	Jul 6, 2026 ↗	View →
TAK TAKEDA PHARMACEUTICAL CO LTD	PURCHASEGRANT Stock grant	105,416	—	—	430,145	Apr 27, 2026	Apr 27, 2026 ↗	View →

Other insiders · TAK

Loading peer insiders…

About this filer

CIK 0001977732

ROLE

CEO - Elect

PRIMARY

TAK

COMPANIES

ACTIVE SINCE

Apr 2026

MARKETPEEL · /INSIDER/0001977732DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE

The morning brief, before the bell.